NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.83
0.00 (0.00%)
At close: Aug 15, 2025, 1:49 PM

NeuroOne Medical Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-6.6M -7.19M -12.32M -12.1M -12.8M -13.47M -11.86M -10.1M -9.39M -8.92M -10M -11.27M -11.46M -10.8M -9.95M -7.87M -12.01M -10.96M
Depreciation & Amortization
258K 253.26K 246.79K 245.17K 239.02K 222.03K 199.27K 170.18K 144.73K 129.35K 118.62K 107.56K 96.41K 87.17K 80.75K 72.15K 64.67K 56.45K
Stock-Based Compensation
1.27M 1.38M 1.34M 1.28M 1.23M 1.11M 1.11M 1.09M 1.05M 1.04M 947.21K 1.03M 1.66M 1.75M 1.79M 1.78M 1.29M 1.49M
Other Working Capital
-276.38K -344.99K -418.26K -467.4K -13.3K -20.85K -1.19M 237.97K 45.45K -276.23K 1.1M -238.02K -471.21K -549.9K -31.59K -298.17K -15.17K 73.14K
Other Non-Cash Items
211.38K 800.13K 1.64M 1.08M 1.08M 863.48K 89.59K 181.99K 181.43K 201.22K 200.68K 105.35K 9.15K -4.56K -15.87K 430.71K 6M 5.95M
Deferred Income Tax
n/a n/a -771.79K -739.65K -744.22K -744.22K 6.81K -25.33K -20.77K -20.77K n/a n/a n/a n/a -1.97K -1.97K 1.92M 1.89M
Change in Working Capital
-9.72K -2.04M -954.61K -812.69K -637.78K -1.19M -2.43M -284.44K -627.55K -761.87K 1.21M -544.63K -521.5K -414.62K -512.73K -716.19K -579.51K -644.84K
Operating Cash Flow
-4.88M -6.99M -11.01M -11.25M -11.83M -13.2M -12.89M -8.97M -8.66M -8.33M -7.52M -10.57M -10.22M -9.38M -8.6M -6.3M -5.23M -4.1M
Capital Expenditures
-79.29K -107.48K -120.2K -140.91K -265.4K -409.74K -384.12K -392.68K -307.62K -225.25K -275.23K -244.15K -219.83K -128.57K -67.08K -88.33K -84.26K -112.16K
Cash Acquisitions
n/a n/a n/a 7.5K 7.5K 7.5K -19.08K 2.94M 2.94M 2.94M 2.97M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a -1.47M -4.94M -4.94M -4.94M -3.47M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a 1M 3M 4.5M 5M 4M 2M 500K n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 7.5K 1.01M 1.01M 1.03M -1.94M -2.94M -2.94M -2.97M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-79.29K -107.48K -120.2K -133.41K 742.1K 2.6M 2.65M -335.64K -1.25M -3.17M -3.24M -244.15K -219.83K -128.57K -67.08K -88.33K -84.26K -112.16K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.05K 3.05K 3.05K 3.05K n/a 4.16M 4.16M
Common Stock Repurchased
-93.52K 2.29K n/a -80.16K -45.62K -132.98K -119.42K -110.84K -98.65K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.72M 1.66M 1.48M -1.07M -1.05M -1.09M -1.07M -234.72K -183.36K -16.04K -1.33M -1.36M -1.32M -3.62M 2.7M 2.59M 2.73M 5.01M
Financial Cash Flow
4.48M 6.2M 7.27M 9.92M 9.92M 8.62M 7.4M 2.21M 646.25K -16.04K 12.02M 12M 12.03M 18.56M 11.53M 11.56M 15.85M 9.3M
Net Cash Flow
-1.11M -1.55M -3.86M -1.46M -1.17M -1.99M -2.84M -7.09M -9.27M -11.52M 1.26M 1.19M 1.59M 9.06M 2.86M 5.17M 10.53M 5.08M
Free Cash Flow
-4.95M -7.1M -11.13M -11.39M -12.09M -13.61M -13.27M -9.36M -8.97M -8.56M -7.79M -10.81M -10.44M -9.51M -8.67M -6.39M -5.32M -4.22M